Startups
Products in development and in clinical trials are accurate and simple to use genomic and proteomic tools for the earlier detection, improved characterisation and better management of gastric, bladder, colorectal cancers and melanoma. The company has completed and released its first product for bladder cancer detection, Cxbladder, and is actively marketing the product to physicians and clinicians in New Zealand, Australia and the USA and soon in Spain.
Pacific Edge takes its exciting cancer detection tests to market through its wholly owned subsidiaries, Pacific Edge Diagnostics NZ Ltd and Pacific Edge Diagnostics USA Ltd, and selected commercial partners in Australia and Spain, Healthscope and Oryzon respectively.
www.pacificedgedx.com
Pacific Edge takes its exciting cancer detection tests to market through its wholly owned subsidiaries, Pacific Edge Diagnostics NZ Ltd and Pacific Edge Diagnostics USA Ltd, and selected commercial partners in Australia and Spain, Healthscope and Oryzon respectively.
www.pacificedgedx.com
Overview
Location
United States, Pennsylvania, Hummelstown
Employees
51-200
Phone
+64 3-479 5800
Founded date
2001
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 8, 2022 | STRATA Study to Validate Cxbladder Utility Reaches 50% Enrolment | Current AUA risk stratification protocols based on clinical risk factors alone are insufficient to reliably de-intensify urological evaluation for low-risk patients. We expect the STRATA study to demonstrate how Cxbladder can satisfy this u... |
| May 31, 2022 | Pacific Edge Appoints Vice President of Medical Affairs | Tamer is well respected in the urological community and has proven he has the skills needed to establish and grow a world class Medical Affairs Team. We are looking forward to him joining the company. Hershey, Pa. (PRWEB) May 31, 2022 Cance... |
| May 11, 2022 | LOBSTER Clinical Trial to Advance Cxbladder Monitor as a Standard of Care | Cxbladder is a non-invasive genomic urine test optimized for the detection and management of bladder cancer. LOBSTER builds on previous validation and clinical utility studies showing that Cxbladder can be incorporated into a surveillance s... |
| Feb 7, 2022 | MTI Wireless Edge Ltd Announces That Its Distribution & Professional Consulting Services Division Has Secured Two Orders Totaling USD 1.6 Million | MTI Wireless Edge Ltd. announced that its Distribution & Professional Consulting Services division has secured two orders totaling USD 1.6 million. The orders, which are for USD 0.8 million each, were received by PSK and MTI Summit and ... |
| Nov 25, 2021 | Pacific Edge : 1H22 Interim Results Presentation | 1H22 INTERIM RESULTS PRESENTATION FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021 25 November 2021 DISCLAIMER Important Notice This presentation has been prepared by Pacific Edge Limited (PEL) solely to provide interested parties with further in... |
Reviews 0
FAQ about Pacific Edge Ltd
When was Pacific Edge Ltd founded?
Pacific Edge Ltd was founded in 2001.
What has the press written about Pacific Edge Ltd?
Parsers VC has collected 6 articles mentioning Pacific Edge Ltd, among them “STRATA Study to Validate Cxbladder Utility Reaches 50% Enrolment” (Jul 8, 2022) and “Pacific Edge Appoints Vice President of Medical Affairs” (May 31, 2022).
Is Pacific Edge Ltd still active?
Yes, Pacific Edge Ltd is active; its latest activity on Parsers VC dates from Mar 14, 2023.